Company: VRCA
Filing Date: 2025-04-30
Form Type: DEFR14A
Source: 0001193125-25-105562
Chunk: 21

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-30
Form: DEFR14A
Chunk 21
---
 is composed of two directors: Mr. Prygocki and Dr. Eichenfield. Dr. Eichenfield serves as the Chair of the Nominating and Corporate Governance Committee. All members of the Nominating and Corporate Governance Committee are independent (as independence is currently defined in Rule 5605(a)(2) of the Nasdaq listing standards). The Nominating and Corporate Governance Committee met one time during 2024. The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to stockholders on the Company’s website at www.verrica.com. The Nominating and Corporate Governance Committee’s responsibilities include:

| • |     | identifying, reviewing, evaluating and recommending candidates to serve on our Board of Directors; |

| • |     | determining the minimum qualifications for service on our board of director; |

| • |     | evaluating director performance on the board and applicable committees of the board and determining whether continued service on our board is appropriate; |

| • |     | evaluating nominations by stockholders of candidates for election to our Board of Directors; |

| • |     | considering and assessing the independence of members of our Board of Directors; |

| • |     | evaluating our set of corporate governance policies and principles and recommending to our Board of Directors any changes to such policies and principles; |

| • |     | reviewing and making recommendations to the Board of Directors with respect to management succession planning; |

| • |     | considering questions of possible conflicts of interest of directors as such questions arise; and |

| • |     | reviewing and evaluating on an annual basis the performance of the Nominating and Corporate Governance Committee and the Nominating and Corporate Governance Committee charter. |

**The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also intends to consider such factors as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the 14

commitment to rigorously represent the long-term interests of the Company’s stockholders. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates for director nominees are reviewed in the context of the current